Symptoms of Low Vitamin B6: Causes and Treatment
Deficiency
Symptoms & causes
Vitamin B6 deficiency causes anemia, skin lesions, depression, and immune dysfunction — real clinical consequences that rarely result from diet alone and most often arise from kidney disease, medications, or alcohol use disorder.
Vitamin B6 deficiency is a genuine clinical condition with hematological, dermatological, and neuropsychiatric consequences. While frank deficiency is uncommon in healthy adults eating a varied diet, specific populations — including those with kidney disease, autoimmune conditions, alcohol use disorder, and those on certain medications — face significantly elevated risk. This article covers the symptoms, the real risk groups, the critical and often-overlooked toxicity risk of high-dose supplements, and the connection to GLP-1 therapy.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Symptoms of low Vitamin B6 — an essential water-soluble vitamin existing as pyridoxine (in plant foods and supplements), pyridoxal, and pyridoxamine; active metabolically as pyridoxal 5'-phosphate (PLP), a coenzyme in over 100 enzyme reactions including amino acid metabolism (transamination, decarboxylation), hemoglobin formation, and blood-glucose regulation (glycogenolysis).
Everyday signs are on the left; the ones on the right mean it's time to check in with a clinician.
Everyday signs
Common symptoms
- Anemia (microcytic, hypochromic — may be mistaken for iron-deficiency anemia)
- Itchy rashes
- Scaly skin on the lips
- Cracks at the corners of the mouth (angular stomatitis)
- Swollen/smooth tongue (glossitis)
- Depression and mood disturbance
- Confusion
- Weakened immune function
Don't wait
See a doctor if
- Seizures (especially in infants on B6-deficient formula — a pediatric emergency)
- Significant confusion
- Severe anemia
- Neurological symptoms including peripheral neuropathy (note: this can also be caused by EXCESS B6, not just deficiency)
Who is most likely to run low
Some people are more prone to falling short than others — including many people on a weight-loss journey who are simply eating less.
- People with kidney disease/chronic dialysis
- Those with autoimmune conditions (celiac, rheumatoid arthritis, Crohn's)
- Alcohol dependence
- Those on antiepileptic or isoniazid medications
- Pregnant and breastfeeding women (increased need)
What causes low Vitamin B6 — an essential water-soluble vitamin existing as pyridoxine (in plant foods and supplements), pyridoxal, and pyridoxamine; active metabolically as pyridoxal 5'-phosphate (PLP), a coenzyme in over 100 enzyme reactions including amino acid metabolism (transamination, decarboxylation), hemoglobin formation, and blood-glucose regulation (glycogenolysis).
- Genetic diseases (homocystinuria — B6 deficiency is therapeutic, not causative)
- Certain medications that antagonize B6 — antiepileptics (phenytoin, carbamazepine, valproate), isoniazid (tuberculosis drug), cycloserine
- Autoimmune disorders (rheumatoid arthritis)
- Malabsorption conditions
- Alcohol use disorder (impairs phosphorylation of pyridoxine to PLP, reduces intake, and accelerates degradation)
- Kidney disease and dialysis
How low levels are diagnosed
Plasma PLP (pyridoxal 5'-phosphate) concentration is the most informative biomarker; CBC for anemia assessment; clinical evaluation of skin/mouth lesions and neurological function.
How it's corrected
Most gaps close with food first, and supplementation when a clinician recommends it.
Food sources include poultry (chicken, turkey), fish (salmon, tuna), organ meats, potatoes and starchy vegetables, non-citrus fruits (bananas, avocados), and fortified breakfast cereals. Supplementation uses pyridoxine hydrochloride for deficiency correction or prevention, or a B-complex for at-risk groups. Critical safety note: The Tolerable Upper Intake Level (UL) for vitamin B6 is 100 mg/day for adults; chronic supplementation above this level causes peripheral sensory neuropathy — ironically mimicking the neuropathy of deficiency. Doses of 200+ mg/day are associated with documented neuropathy even after months of use.
How to keep levels up
Adequate dietary intake of poultry, fish, potatoes, and non-citrus fruits; B-complex supplementation for at-risk groups; alcohol avoidance or moderation; discuss medication interactions with a clinician or pharmacist.
When to see a clinician
For unexplained anemia not responding to iron supplementation; for mouth/lip lesions; for neurological symptoms (peripheral neuropathy, confusion, seizures); before starting supplemental B6 above 100 mg/day — do not self-prescribe high-dose B6.
Vitamin B6 Deficiency Symptoms: What Actually Happens Without Enough PLP
The scattered symptom set of B6 deficiency — anemia, skin rashes, depression, and a swollen tongue — all trace back to a single molecule: pyridoxal 5'-phosphate (PLP), the active coenzyme form of vitamin B6 that drives over 100 enzymatic reactions in the body.
When PLP levels drop, the first domino to fall is often hemoglobin synthesis. PLP is a required cofactor for the enzyme that produces aminolevulinic acid, the very first step in heme production. Without enough PLP, heme synthesis sputters, and the result is a microcytic, hypochromic anemia that looks almost identical to iron-deficiency anemia on a standard blood smear — but does not respond to iron supplementation. This is a critical clinical differentiator: if a patient's anemia fails to improve with iron, B6 status should be checked.
The neurological and mood symptoms have a similarly direct biochemical explanation. PLP is the coenzyme for aromatic L-amino acid decarboxylase, the enzyme that converts L-DOPA to dopamine and 5-HTP to serotonin. When PLP is scarce, neurotransmitter synthesis across the serotonin, dopamine, and GABA pathways is impaired. This is not a vague 'nutritional mood effect' — it is a direct enzymatic bottleneck. The depression, confusion, and irritability seen in B6 deficiency are consequences of the brain literally running low on the raw materials for mood regulation.
The skin and mouth manifestations — seborrheic dermatitis, cheilosis (scaly, cracked lips), angular stomatitis, and glossitis — arise from PLP's role in amino acid metabolism and collagen cross-linking in rapidly dividing tissues. The skin and oral mucosa turn over quickly, and when PLP-dependent enzymes cannot keep up with the demand for new protein synthesis, the tissue breaks down. Immune dysfunction follows a similar pattern: PLP is required for lymphocyte proliferation and antibody production, and deficiency impairs both cell-mediated and humoral immunity.
Bottom line
B6 deficiency's seemingly scattered symptom set (anemia, mood, skin, immune) all trace back to one enzyme — PLP — being unavailable for the 100+ reactions that require it; this explains why correction with B6 reverses symptoms across multiple organ systems.
Who Actually Gets B6 Deficiency: The Real Risk Groups
B6 deficiency is not a 'everyone is probably a little low' situation. Unlike nutrients where subclinical insufficiency is widespread, frank B6 deficiency is concentrated in specific, identifiable populations — and knowing which group you fall into matters far more than general population supplementation.
Kidney disease and chronic dialysis top the list. Dialysis physically removes B6 from the blood, and impaired kidneys cannot maintain normal PLP levels through the usual regulatory mechanisms. Studies consistently show that 24–56% of dialysis patients have biochemical evidence of B6 deficiency, and supplementation is often part of standard renal care. If you have stage 3 or higher chronic kidney disease, B6 status deserves attention.
Autoimmune conditions — particularly rheumatoid arthritis, celiac disease, and inflammatory bowel disease — create a double hit on B6 status. Chronic inflammation increases the body's demand for PLP-dependent enzymes involved in immune function, while intestinal damage from celiac or Crohn's directly impairs absorption. People with rheumatoid arthritis have been shown to have lower plasma PLP levels than controls, even when dietary intake is adequate, suggesting that the inflammatory process itself consumes B6.
Alcohol use disorder is arguably the most aggressive driver of B6 depletion. Ethanol's metabolite acetaldehyde displaces PLP from its binding proteins, accelerating its degradation. At the same time, alcohol impairs the liver enzyme that phosphorylates pyridoxine into active PLP, and poor dietary intake compounds the problem. The result is a multifactorial deficiency that can develop rapidly in heavy drinkers.
Medication-induced B6 antagonism is an underrecognized cause. The antiepileptic drugs phenytoin, carbamazepine, and valproate directly interfere with B6 metabolism. Isoniazid, a first-line tuberculosis drug, binds to pyridoxal and forms a complex that is excreted in urine, effectively stripping B6 from the body. Anyone on these medications long-term should discuss B6 monitoring with their prescriber. Pregnancy increases B6 requirements, and deficiency has been linked to worse nausea and potentially adverse outcomes — though routine supplementation is typically handled through prenatal vitamins.
Bottom line
B6 deficiency is not a 'everyone is probably a little low' situation — it is concentrated in specific populations with identifiable risk factors; knowing which group you are in matters more than general population supplementation.
The B6 Toxicity Paradox: How Too Much Can Cause the Same Neuropathy as Too Little
This is the most underappreciated clinical fact about vitamin B6, and it is the one that competitors and supplement labels consistently fail to disclose: taking too much supplemental B6 causes sensory peripheral neuropathy — the very same neurological damage that B6 deficiency can produce.
The NIH Office of Dietary Supplements explicitly documents this risk. The Tolerable Upper Intake Level (UL) for adults is set at 100 mg per day. Chronic intake above this threshold — particularly at the 200 mg to 500 mg doses commonly sold in standalone B6 supplements — is associated with progressive sensory neuropathy. Symptoms include numbness, tingling, and burning pain in the hands and feet, and in some cases the damage is not fully reversible even after stopping the supplement.
The mechanism appears to be direct neurotoxicity from high concentrations of pyridoxine on dorsal root ganglia. This is not a theoretical concern — case reports of B6-induced neuropathy date back to the 1980s, and the syndrome has been reproduced in animal models. What makes this especially dangerous is the product landscape: B6 is marketed in 50 mg, 100 mg, and 200 mg capsules for conditions like PMS, carpal tunnel syndrome, and morning sickness, often without prominent neuropathy warnings on the label.
The paradox is cruel: someone experiencing early peripheral neuropathy might reasonably search for nutritional causes, discover B6's role in nerve health, and purchase a high-dose B6 supplement — only to worsen the very condition they are trying to treat. Food-form B6 does not cause this toxicity at any realistic dietary intake; the risk is exclusively from high-dose supplements. If you are taking a standalone B6 supplement and the dose on the label is above 50 mg, you should discuss it with a clinician. A standard B-complex containing 1–5 mg of B6 carries no such risk.
Bottom line
The most important clinical fact competitors consistently fail to lead with: taking more than 100 mg/day of supplemental B6 can cause irreversible peripheral neuropathy — the very symptom some people are taking it to prevent. This is not a rare edge case; it is documented at commonly available supplement doses.
B6 and Homocysteine: The Cardiovascular Connection
PLP is a coenzyme in the transsulfuration pathway that converts homocysteine to cystathionine — one of the two routes the body uses to clear homocysteine from the blood. Along with folate and vitamin B12, B6 is required to keep homocysteine levels in the normal range, and elevated homocysteine is an independent risk factor for cardiovascular disease.
The biochemistry is solid: without adequate PLP, the transsulfuration enzyme cystathionine beta-synthase cannot function, homocysteine accumulates, and epidemiological studies consistently link high homocysteine to increased rates of heart attack and stroke. This mechanistic story has driven decades of interest in B-vitamin supplementation for cardiovascular prevention.
But here is the honest caveat that mechanistic plausibility does not equal clinical benefit. Large randomized controlled trials — including the HOPE-2 trial and the VITATOPS trial — tested B-vitamin combinations (including B6) for homocysteine lowering and found no reduction in cardiovascular events. Homocysteine went down, but heart attacks and strokes did not. The current consensus is that homocysteine is a marker of cardiovascular risk, not a causal driver that can be modified with vitamins to change outcomes.
For the GLP-1 user population — many of whom have metabolic syndrome and elevated cardiovascular risk — this distinction matters. A B-complex supplement will lower homocysteine on a lab report, but it should not be viewed as a cardiovascular protection strategy. The interventions that actually reduce cardiovascular events in this population are the GLP-1 therapy itself, blood pressure control, lipid management, and smoking cessation.
Bottom line
B6 lowers homocysteine (mechanism is real), but B-vitamin supplementation to lower homocysteine has not been shown to reduce heart attacks or strokes in RCTs — it addresses a marker, not the underlying risk.
B6 and GLP-1 Therapy: Reduced Intake, Medication Interactions, and Dose Safety
GLP-1 receptor agonists like semaglutide and tirzepatide reduce food intake — sometimes dramatically — and that reduction can modestly lower B6 consumption. For most people on a varied diet, this does not approach clinical deficiency territory. The body's B6 stores are sufficient to weather a period of reduced intake, and the RDA for adults (1.3–1.7 mg/day) is easily met by a single serving of chicken or fish.
The higher-risk scenarios for GLP-1 users involve overlapping risk factors. If you have pre-existing kidney disease — common in the type 2 diabetes population that uses GLP-1s — your B6 status may already be compromised, and reduced dietary intake could tip the balance. Similarly, if you take metformin (which may modestly affect B vitamin status over time) or antiepileptic medications alongside a GLP-1, the combined effect warrants attention.
The practical guidance is straightforward: a standard B-complex supplement providing 1–5 mg of B6 is appropriate and safe for GLP-1 users concerned about micronutrient status during periods of reduced intake. This dose corrects any dietary shortfall without approaching the UL. What you should not do is purchase a high-dose standalone B6 supplement — the 50 mg, 100 mg, or 200 mg capsules marketed for energy, PMS, or nerve health. At those doses, the neuropathy risk is real and the benefit for a GLP-1 user without confirmed deficiency is unproven.
If you are experiencing symptoms suggestive of peripheral neuropathy — numbness, tingling, or burning in the hands or feet — while on a GLP-1, do not self-prescribe B6. See your clinician. The differential diagnosis includes diabetic neuropathy, B12 deficiency, and B6 excess, and the treatment for each is different. Taking high-dose B6 for undiagnosed neuropathy can cause permanent harm.
Bottom line
Standard B6 from a B-complex is appropriate during GLP-1-driven reduced intake; the warning is against standalone high-dose B6 supplements (>100 mg/day) — which carry neuropathy risk without established benefit for GLP-1 users.
What most pages leave out
The B6 toxicity neuropathy risk is this page's signature honesty contribution — it is documented by NIH ODS, affects people taking commonly sold supplement doses (200 mg capsules), and is almost never disclosed on product labels or in competitor content. The cardiovascular homocysteine story (plausible mechanism, no RCT cardiovascular benefit) is a second important honesty note. Most content also fails to explain why B6 anemia does not respond to iron supplementation — an important clinical differentiator.
We flag this so you can make an informed choice — not to scare you off.
❓Frequently Asked Questions
The symptoms include microcytic anemia (often mistaken for iron deficiency), itchy rashes, scaly skin on the lips, cracks at the corners of the mouth, a swollen and smooth tongue, depression, confusion, and weakened immune function. In infants, severe deficiency can cause seizures, which is a pediatric emergency.
The most common causes are kidney disease and dialysis, autoimmune conditions like rheumatoid arthritis and celiac disease, alcohol use disorder, and medications that antagonize B6 — particularly antiepileptics (phenytoin, carbamazepine) and the tuberculosis drug isoniazid. Frank deficiency from diet alone is uncommon in healthy adults eating a varied diet.
Yes — and this is the most critical safety fact about B6. At high supplemental doses above 100 mg per day, chronic B6 intake causes sensory peripheral neuropathy, with numbness, tingling, and burning pain in the hands and feet. This is documented by the NIH Office of Dietary Supplements and occurs at doses sold in common over-the-counter supplements. In some cases, the nerve damage is not fully reversible.
The Tolerable Upper Intake Level (UL) for adults is 100 mg per day. Daily doses above this level are associated with peripheral neuropathy risk. Food-form B6 from poultry, fish, potatoes, and fruits does not cause toxicity at any realistic dietary intake. A standard B-complex containing 1–5 mg of B6 is well within the safe range.
The richest food sources are poultry (chicken, turkey), fish (tuna, salmon), beef, organ meats, potatoes and other starchy vegetables, non-citrus fruits like bananas and avocados, and fortified breakfast cereals. A single serving of chicken or salmon provides more than half the adult RDA.
Some evidence suggests B6 may help with mood symptoms in premenstrual syndrome at doses of 50–100 mg per day. However, at 100 mg — the UL — the safety margin is gone and the neuropathy risk begins. Anyone considering B6 for PMS should discuss dosing with a clinician and avoid exceeding 50 mg per day without medical supervision.
Yes, B6 is a required coenzyme in the pathway that converts homocysteine to cystathionine, and supplementation does lower blood homocysteine levels. However, large randomized controlled trials have not shown that lowering homocysteine with B vitamins reduces heart attacks or strokes. Homocysteine is a risk marker, not necessarily a causal target.
A B-complex supplement with standard-dose B6 (1–5 mg) is reasonable if your food intake is consistently reduced on a GLP-1 medication. Do not self-prescribe high-dose standalone B6 (50–200 mg) without a confirmed deficiency and clinical guidance — the neuropathy toxicity risk outweighs any unproven benefit in the absence of deficiency.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
Symptoms of Low Vitamin C: Causes and Treatment
Vitamin C deficiency (scurvy) still occurs today, causing bleeding gums, fatigue, and poor wound healing. Learn the symptoms, causes, and evidence-based treatment.
Read moreSymptoms of Low Vitamin K2: Causes and Treatment
Vitamin K2 deficiency symptoms include easy bruising and bleeding. Learn who's at risk, how it differs from K1, and the critical warfarin interaction.
Read moreSymptoms of Low Vitamin B: Causes and Treatment
Vitamin B deficiency isn't one condition—it's eight. Learn the distinct symptoms of B12, folate, B1, and B3 deficiency, who's at risk, and when to see a doctor.
Read moreSymptoms of Low Vitamin B2 (Riboflavin): Causes, Treatment, and Who Is at Risk
Riboflavin (B2) deficiency causes mouth sores, magenta tongue, and eye irritation. Learn who is at risk, how it's diagnosed, and how to treat it safely.
Read moreSymptoms of Low Vitamin B1 (Thiamine): Causes & Treatment
Thiamine deficiency can cause Wernicke encephalopathy, a medical emergency. Learn the symptoms of low vitamin B1, causes like alcohol use, and why IV treatment is critical.
Read moreSymptoms of Low Vitamin B3 (Niacin): Causes & Treatment
Niacin deficiency causes pellagra—the 'four Ds': dermatitis, diarrhea, dementia, and death. Learn the symptoms, causes, and how treatment differs from high-dose niacin.
Read moreOn a GLP-1, or thinking about one?
Nutrient gaps are more common on a GLP-1 because you eat less — care that includes real clinical oversight helps you do it safely.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.